Dr. Humayun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1450 San Pablo St
Ste 4000
Los Angeles, CA 90033Phone+1 323-442-6311Fax+1 323-442-7166
Education & Training
- Duke University HospitalResidency, Ophthalmology, 1990 - 1993
- Carilion Clinic-Virginia Tech Carilion School of MedicineInternship, Transitional Year, 1989 - 1990
- Duke University School of MedicineClass of 1989
Certifications & Licensure
- CA State Medical License 1993 - 2025
- MD State Medical License 1993 - 2002
- FL State Medical License 1994 - 2000
- NC State Medical License 1990 - 1998
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Join now to see all
Publications & Presentations
PubMed
- 53 citationsIntraocular retinal prosthesisMark S. Humayun
Transactions of the American Ophthalmological Society. 2001-01-01 - 314 citationsMorphometric analysis of macular photoreceptors and ganglion cells in retinas with retinitis pigmentosa.John L. Stone, William E. Barlow, Mark S. Humayun, Eugene de Juan, Ann H. Milam
Archives of Ophthalmology. 1992-11-01 - 213 citationsThe Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision lossLyndon da Cruz, Brian Coley, Jessy D. Dorn, Francesco Merlini, Eugene Filley
The British Journal of Ophthalmology. 2013-05-01
Authored Content
- Targeted Stimulation of Retinal Ganglion Cells in Epiretinal Prostheses: A Multiscale Computational StudySeptember 2020
Press Mentions
- NS/ a Single Memory Is Stored Across Many Connected Brain RegionsApril 14th, 2022
- Regenerative Patch Technologies Presents Clinical Data Demonstrating Long-Term Survival and Function of an Allogenic Bioengineered Cellular Implant in Patients with Advanced Dry Aged-Related Macular DegenerationFebruary 4th, 2022
- Earning a Place at the TableSeptember 30th, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: